Full text
PDFPage 508
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gangadhar B. N., Desai N. G., Channabasavanna S. M. Amantadine in the neuroleptic malignant syndrome. J Clin Psychiatry. 1984 Dec;45(12):526–526. [PubMed] [Google Scholar]
- Guzé B. H., Baxter L. R., Jr Current concepts. Neuroleptic malignant syndrome. N Engl J Med. 1985 Jul 18;313(3):163–166. doi: 10.1056/NEJM198507183130306. [DOI] [PubMed] [Google Scholar]
- Hamburg P., Weilburg J. B., Cassem N. H., Cohen L., Brown S. Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy. Compr Psychiatry. 1986 Jul-Aug;27(4):272–275. doi: 10.1016/0010-440x(86)90002-7. [DOI] [PubMed] [Google Scholar]
- Levenson J. L. Neuroleptic malignant syndrome. Am J Psychiatry. 1985 Oct;142(10):1137–1145. doi: 10.1176/ajp.142.10.1137. [DOI] [PubMed] [Google Scholar]
- McCarron M. M., Boettger M. L., Peck J. J. A case of neuroleptic malignant syndrome successfully treated with amantadine. J Clin Psychiatry. 1982 Sep;43(9):381–382. [PubMed] [Google Scholar]
- Rojtman M., Apter E., Lahav S., Tiano S. [Amantadine in malignant neuroleptic syndrome]. Harefuah. 1981 Apr 1;100(7):333–333. [PubMed] [Google Scholar]
- Shalev A., Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986 Apr;73(4):337–347. doi: 10.1111/j.1600-0447.1986.tb02694.x. [DOI] [PubMed] [Google Scholar]
- Woo J., Teoh R., Vallance-Owen J. Neuroleptic malignant syndrome successfully treated with amantidine. Postgrad Med J. 1986 Aug;62(730):809–810. doi: 10.1136/pgmj.62.730.809-a. [DOI] [PMC free article] [PubMed] [Google Scholar]